228 related articles for article (PubMed ID: 34624238)
1. A comprehensive approach to therapy of haematological malignancies in older patients.
Cordoba R; Eyre TA; Klepin HD; Wildes TM; Goede V
Lancet Haematol; 2021 Nov; 8(11):e840-e852. PubMed ID: 34624238
[TBL] [Abstract][Full Text] [Related]
2. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
[TBL] [Abstract][Full Text] [Related]
3. Biannual report of the Cochrane Haematological Malignancies Group.
Trelle S; Higgins G; Kober T; Engert A
J Natl Cancer Inst; 2004 Aug; 96(15):E2. PubMed ID: 15292394
[No Abstract] [Full Text] [Related]
4. Individualizing treatment decisions for older adults with hematologic malignancies.
Klepin HD; Rizzieri D; Palumbo A; Magarotto V; Eichhorst B
Am Soc Clin Oncol Educ Book; 2013; ():208-19. PubMed ID: 23714504
[TBL] [Abstract][Full Text] [Related]
5. Third biannual report of the Cochrane Haematological Malignancies Group.
Kober T; Skoetz N; Trelle S; Bohlius J; Engert A;
J Natl Cancer Inst; 2005 Aug; 97(16):E2. PubMed ID: 16106014
[No Abstract] [Full Text] [Related]
6. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis and management of immune dysfunction secondary to B cell haematological malignancies.
Crassini K; Gibson J
Intern Med J; 2024 Jan; 54(1):16-25. PubMed ID: 38066723
[TBL] [Abstract][Full Text] [Related]
8. Exploring Big Data in Hematological Malignancies: Challenges and Opportunities.
Westin GF; Dias AL; Go RS
Curr Hematol Malig Rep; 2016 Aug; 11(4):271-9. PubMed ID: 27177742
[TBL] [Abstract][Full Text] [Related]
9. [Hematology 2009].
Dreyling M; Spiekermann K; Hiddemann W
Dtsch Med Wochenschr; 2009 Jun; 134(25-26):1367-9. PubMed ID: 19517333
[No Abstract] [Full Text] [Related]
10. [Incidence of haematological malignancies in adults in Szabolcs-Szatmár-Bereg county, Hungary, between 1983 and 2012. Analysis of data from a thirty-year period].
Jakó J; Szerafin L; Nagy P
Orv Hetil; 2013 Nov; 154(47):1858-64. PubMed ID: 24240522
[TBL] [Abstract][Full Text] [Related]
11. From genomics to targeted treatment in haematological malignancies: a focus on acute myeloid leukaemia.
Jakobsen NA; Vyas P
Clin Med (Lond); 2018 Apr; 18(Suppl 2):s47-s53. PubMed ID: 29700093
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cell transplantation in hematologic malignancy.
Archuleta TD; Devetten MP; Armitage JO
Panminerva Med; 2004 Mar; 46(1):61-74. PubMed ID: 15238882
[TBL] [Abstract][Full Text] [Related]
13. Distribution pattern and prevalence of haematological cancers among adults in Abakaliki, South-Eastern Nigeria.
Ugwu NI; Okoye AE; Ugwu CN; Iyare FE; Edegbe FO; Ugwu GC; Chukwurah EF; Richard IC; John DO; Nnadozie UU; Nwokwu EU
Niger Postgrad Med J; 2021; 28(4):266-272. PubMed ID: 34850754
[TBL] [Abstract][Full Text] [Related]
14. Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic.
Di Ciaccio P; McCaughan G; Trotman J; Ho PJ; Cheah CY; Gangatharan S; Wight J; Ku M; Quach H; Gasiorowski R; Polizzotto MN; Prince HM; Mulligan S; Tam CS; Gregory G; Hapgood G; Spencer A; Dickinson M; Latimer M; Johnston A; Armytage T; Lee C; Cochrane T; Berkhahn L; Weinkove R; Doocey R; Harrison SJ; Webber N; Lee HP; Chapman S; Campbell BA; Gibbs SDJ; Hamad N
Intern Med J; 2020 Jun; 50(6):667-679. PubMed ID: 32415723
[TBL] [Abstract][Full Text] [Related]
15. Changing causes of death in persons with haematological cancers 1975-2016.
Chen L; Zheng Y; Yu K; Chen S; Wang W; Gale RP; Liu ZX; Liang Y
Leukemia; 2022 Jul; 36(7):1850-1860. PubMed ID: 35577905
[TBL] [Abstract][Full Text] [Related]
16. Updates on Hematologic Malignancies in the Older Adult: Focus on Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Huang LW; Wong SW; Andreadis C; Olin RL
Curr Oncol Rep; 2019 Mar; 21(4):35. PubMed ID: 30848394
[TBL] [Abstract][Full Text] [Related]
17. Hypercoagulability in patients with haematological neoplasia: no apparent initiation by tissue factor.
Negaard HF; Iversen PO; Østenstad B; Iversen N; Holme PA; Sandset PM
Thromb Haemost; 2008 Jun; 99(6):1040-8. PubMed ID: 18521506
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic approaches to haematological malignancies in adolescents and young adults.
Place AE; Frederick NN; Sallan SE
Br J Haematol; 2014 Jan; 164(1):3-14. PubMed ID: 24007213
[TBL] [Abstract][Full Text] [Related]
19. Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies.
Thanarajasingam G; Minasian LM; Baron F; Cavalli F; De Claro RA; Dueck AC; El-Galaly TC; Everest N; Geissler J; Gisselbrecht C; Gribben J; Horowitz M; Ivy SP; Jacobson CA; Keating A; Kluetz PG; Krauss A; Kwong YL; Little RF; Mahon FX; Matasar MJ; Mateos MV; McCullough K; Miller RS; Mohty M; Moreau P; Morton LM; Nagai S; Rule S; Sloan J; Sonneveld P; Thompson CA; Tzogani K; van Leeuwen FE; Velikova G; Villa D; Wingard JR; Wintrich S; Seymour JF; Habermann TM
Lancet Haematol; 2018 Nov; 5(11):e563-e598. PubMed ID: 29907552
[TBL] [Abstract][Full Text] [Related]
20. Variations in specialist palliative care referrals: findings from a population-based patient cohort of acute myeloid leukaemia, diffuse large B-cell lymphoma and myeloma.
Howell DA; Wang HI; Roman E; Smith AG; Patmore R; Johnson MJ; Garry AC; Howard MR
BMJ Support Palliat Care; 2015 Dec; 5(5):496-502. PubMed ID: 24644210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
